bavituximab

01/01/2014 - "In the present paper we summarize the preclinical development and clinical experience with bavituximab in non-small-cell lung cancer."
01/01/2014 - "Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer."
08/01/2011 - "This article summarizes the preclinical development and clinical experience with bavituximab in non-small-cell lung cancer."
08/01/2011 - "Phase II trials of bavituximab in combination with chemotherapy for the first- and second-line treatment of advanced non-small-cell lung cancer are currently ongoing. "
01/01/2018 - "This phase III trial determined the efficacy of bavituximab combined with docetaxel in patients with previously treated advanced non-small-cell lung cancer (NSCLC). "

08/01/2011 - "Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment."
09/01/2007 - "Bavituximab, a chimeric version of 2aG4 in clinical trials, has the potential to enhance the therapeutic efficacy of radiation therapy in lung cancer patients."
01/01/2015 - "Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts."

10/01/2019 - "The objective of this phase II study was to assess the efficacy of combination bavituximab and sorafenib in advanced hepatocellular carcinoma (HCC). "
10/01/2019 - "Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial."
11/01/2021 - "A Phase 2 Clinical Trial of the Phosphatidylserine-Targeting Antibody Bavituximab in Combination With Pembrolizumab in Patients With Advanced Hepatocellular Carcinoma."

08/15/2023 - "Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients."
11/15/2009 - "Bavituximab combined with radiotherapy holds promise as a vascular targeting and immune enhancement strategy for the treatment of human glioblastoma."
11/15/2009 - "Here, we determined whether treatment with the murine equivalent of bavituximab, 2aG4, combined with irradiation can suppress tumor growth in a rat model of glioblastoma. "
08/15/2023 - "We evaluated the efficacy of bavituximab-a mAb with anti-angiogenic and immunomodulatory properties-in newly diagnosed patients with glioblastoma (GBM) who also received radiotherapy and temozolomide. "

07/01/2015 - "Bavituximab in combination with paclitaxel is well tolerated for treatment of patients with metastatic breast cancer with promising results observed in terms of clinical RRs and PFS. "
07/01/2015 - "We conducted a phase I clinical trial of bavituximab in combination with paclitaxel in patients with HER2-negative metastatic breast cancer. "
07/01/2015 - "A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer."